Implant-Grade Silicone Rubber

Implant-Grade Silicone Rubber: The Highest Biocompatibility Tier

Implant-grade silicone rubber represents the most stringently tested and regulated category of silicone materials. Used in devices that maintain long-term or permanent contact with living tissue, implant-grade silicone must pass a comprehensive panel of biocompatibility evaluations defined by international standards — primarily ISO 10993 and USP <88> Class VI biological tests.

Not all "medical-grade" silicone qualifies as implant-grade. The distinction matters critically: materials acceptable for external skin contact or short-term blood contact may not be acceptable for long-term tissue implantation. Procurement and regulatory teams must verify the specific biocompatibility test data for the exact compound, lot, and supplier.

Required Biocompatibility Standards

USP Class VI (USP <88> Biological Reactivity Tests, In Vivo):

• Systemic injection test: Extract injected into mice; observe for systemic toxic response for 72 hours.
• Intracutaneous test: Extract injected intradermally into rabbits; observe for local tissue reaction for 72 hours.
• Implantation test: Material implanted into rabbit muscle; observe tissue response at 7 days and 90 days.

Passing all three in vivo tests confirms that the specific lot of silicone compound does not produce acute systemic toxicity, local dermal irritation, or adverse tissue reaction on implantation.

ISO 10993 Biocompatibility Evaluation: ISO 10993 is the framework standard for biocompatibility evaluation of medical devices. For implant-adjacent or implantable silicone components, the relevant tests typically include:

• ISO 10993-5: Cytotoxicity (in vitro cell viability test)
• ISO 10993-10: Sensitization (Buehler or Maximization test in guinea pigs)
• ISO 10993-11: Systemic toxicity (acute and subacute)
• ISO 10993-6: Local effects after implantation (for permanent implants)
• ISO 10993-13: Identification and quantification of degradation products

Important: USP Class VI passing does not automatically satisfy ISO 10993 requirements. Regulatory bodies (FDA for 510(k)/PMA, ANVISA, NMPA, EU MDR Notified Bodies) require ISO 10993 biocompatibility reports as part of the technical file for implantable devices.

Cure System: Platinum Only

Implant-grade silicone must use platinum addition cure. Peroxide cure systems leave organic decomposition products (primarily benzoic acid derivatives) in the cured compound that cannot be completely removed by post-cure alone. These residues fail the implantation and systemic injection tests at the concentrations present in peroxide-cured compounds.

The platinum catalyst itself is present at very low concentrations (typically 10–50 ppm Pt in the cured compound) and is not considered a biocompatibility risk at these levels. Request platinum content data from your supplier if required for regulatory filings.

Regulatory Pathway Context

FDA (U.S.): Implantable silicone components are regulated under the FDA medical device framework. Depending on the intended use and duration of implantation (per ISO 10993-1 contact category), the device may require 510(k) clearance, PMA approval, or De Novo classification. The silicone raw material supplier's biocompatibility data is incorporated into the device manufacturer's technical file.

EU MDR (2017/745): Under the European Medical Device Regulation, implantable devices are classified as Class III (highest risk class). Conformity assessment requires involvement of a Notified Body and complete ISO 10993 biocompatibility evaluation.

NMPA (China): China's National Medical Products Administration requires GB/T 16886 biocompatibility testing (equivalent to ISO 10993) for medical devices sold in China. Silicone raw material biocompatibility data from Chinese-recognized testing laboratories is required.

Sourcing Implant-Grade Silicone

Implant-grade silicone is available from a limited number of qualified specialty suppliers. When sourcing, request: USP Class VI test report (per compound/per lot), ISO 10993-5 cytotoxicity report, cure system declaration (platinum only), post-cure conditions used, Pt content, and manufacturing site cGMP qualification status.

Contact us to verify certification documents and connect with qualified implant-grade silicone suppliers in our network. Inquiries require application context (device type, implantation duration, body contact category) for proper routing.